Trial Profile
A Multi-center, Double-masked, Randomized, Placebo-controlled Evaluation of the Onset and Duration of Action of KetoNaph Ophthalmic Solution in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Ketotifen/naphazoline (Primary) ; Ketotifen; Naphazoline
- Indications Allergic conjunctivitis
- Focus Registrational; Therapeutic Use
- Sponsors Bausch & Lomb
- 28 Nov 2015 New trial record